CIBRA Capital Increases Stake in Amicus Therapeutics (FOLD) by Over 1 Million Shares
CIBRA Capital significantly increased its stake in Amicus Therapeutics (FOLD) by purchasing 1,476,861 shares, valued at approximately $21.17 million. The move represents a 10.2% increase in the firm's AUM and now accounts for 11.78% of its total assets under management. The stock has seen strong performance, with a 103.7% one-year total return.
Tickers: $FOLD
Topics: merger arbitrage portfolio changes SEC filings stock purchases